Skip to main content
. 2020 Jan 3;34(1):339–346. doi: 10.21873/invivo.11779

Table II. Perioperative and pathological outcomes according to age group.

graphic file with name in_vivo-34-341-i0001.jpg

UFT: Tegafur-uracil; TS-1: tegafur, gimeracil, and oteracil potassium; XELOX: capecitabine and oxaliplatin; FOLFOX: bolus and infused fluorouracil with oxaliplatin. *Categorical variables are presented as proportions. †Categorical data were compared using the chi-square test or Fisher’s exact test.